DE vs DHR: Which Is the Better Buy?

Side-by-side comparison of Deere & Company and Danaher Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-04.
Deere & Company Β· Industrials
$578.39
+22.4% upside to fair value
Grade C
VS
Danaher Corporation Β· Healthcare
$174.04
+13.2% upside to fair value
Grade B
QuantHub Verdict
DE has more upside to fair value (+22.4%). DE trades at a lower forward P/E (32.5x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric DE DHR
Current Price $578.39 $174.04
Fair Value Estimate $708.19 $197.01
Upside to Fair Value +22.4% +13.2%
Market Cap $156.2B $123.2B
Forward P/E 32.5x 33.4x
EV / EBITDA 18.4x 20.3x
Price / Sales 3.4x 5.0x
Price / FCF 43.7x 23.3x
Revenue Growth YoY +16.3% +3.7%
Gross Margin 35.6% 60.7%
Operating Margin 18.5% 21.0%
Return on Equity 18.9% 7.1%
Dividend Yield 0% 0%
FCF Yield 2.29% 4.3%
Analyst Consensus Buy Strong Buy
Investment Thesis
DE β€” Deere & Company
Deere & Company is a leading manufacturer of agricultural, construction, and forestry machinery, with a strong position in production and precision agriculture, small agriculture and turf, and construction and forestry segments. The company benefits from a durable competitive moat driven by its brand, intangible assets, and switching costs, supported by a CEO with deep institutional knowledge and…
DHR β€” Danaher Corporation
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Accumulation Zones
Metric DE DHR
Zone Low $531.14 $147.76
Zone High $601.96 $167.46
In Buy Zone? Yes No
← DE Research    DHR Research β†’    All Research